middle.news
Avecho Secures US$3M Upfront in Landmark Sandoz CBD Insomnia Deal
10:07am on Wednesday 30th of April, 2025 AEST
•
Pharmaceuticals
Read Story
Avecho Secures US$3M Upfront in Landmark Sandoz CBD Insomnia Deal
10:07am on Wednesday 30th of April, 2025 AEST
Key Points
Exclusive 10-year licensing deal with Sandoz for CBD insomnia capsule in Australia
US$3 million upfront payment received, plus US$16 million in development milestones
Tiered royalties of 14% to 19% on net sales post-commercialisation
Phase III clinical trial progressing with new sites added, interim analysis targeted in 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Avecho Biotechnology (ASX:AVE)
OPEN ARTICLE